ArticleTranslational lung cancer research2026

Identification of candidate variants in plasma associated with early versus late disease progression under anti-PD-1 therapy in metastatic NSCLC.

Aitor Rodriguez-Casanova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.